These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21128593)

  • 1. Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
    Parks DJ; Parsons WH; Colburn RW; Meegalla SK; Ballentine SK; Illig CR; Qin N; Liu Y; Hutchinson TL; Lubin ML; Stone DJ; Baker JF; Schneider CR; Ma J; Damiano BP; Flores CM; Player MR
    J Med Chem; 2011 Jan; 54(1):233-47. PubMed ID: 21128593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.
    Calvo RR; Meegalla SK; Parks DJ; Parsons WH; Ballentine SK; Lubin ML; Schneider C; Colburn RW; Flores CM; Player MR
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1903-7. PubMed ID: 22330635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.
    Tamayo NA; Bo Y; Gore V; Ma V; Nishimura N; Tang P; Deng H; Klionsky L; Lehto SG; Wang W; Youngblood B; Chen J; Correll TL; Bartberger MD; Gavva NR; Norman MH
    J Med Chem; 2012 Feb; 55(4):1593-611. PubMed ID: 22329507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.
    Zhu B; Xia M; Xu X; Ludovici DW; Tennakoon M; Youngman MA; Matthews JM; Dax SL; Colburn RW; Qin N; Hutchinson TL; Lubin ML; Brandt MR; Stone DJ; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2234-7. PubMed ID: 23411075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists.
    Horne DB; Tamayo NA; Bartberger MD; Bo Y; Clarine J; Davis CD; Gore VK; Kaller MR; Lehto SG; Ma VV; Nishimura N; Nguyen TT; Tang P; Wang W; Youngblood BD; Zhang M; Gavva NR; Monenschein H; Norman MH
    J Med Chem; 2014 Apr; 57(7):2989-3004. PubMed ID: 24597733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists.
    Ostacolo C; Ambrosino P; Russo R; Lo Monte M; Soldovieri MV; Laneri S; Sacchi A; Vistoli G; Taglialatela M; Calignano A
    Eur J Med Chem; 2013 Nov; 69():659-69. PubMed ID: 24095758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels.
    Ma S; G G; Ak VE; Jf D; H H
    Pak J Pharm Sci; 2008 Oct; 21(4):370-8. PubMed ID: 18930858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
    Matthews JM; Qin N; Colburn RW; Dax SL; Hawkins M; McNally JJ; Reany L; Youngman MA; Baker J; Hutchinson T; Liu Y; Lubin ML; Neeper M; Brandt MR; Stone DJ; Flores CM
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2922-6. PubMed ID: 22421018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Menthylamine derivatives as potent and selective antagonists of transient receptor potential melastatin type-8 (TRPM8) channels.
    Ortar G; De Petrocellis L; Morera L; Moriello AS; Orlando P; Morera E; Nalli M; Di Marzo V
    Bioorg Med Chem Lett; 2010 May; 20(9):2729-32. PubMed ID: 20378345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
    Chaudhari SS; Kadam AB; Khairatkar-Joshi N; Mukhopadhyay I; Karnik PV; Raghuram A; Rao SS; Vaiyapuri TS; Wale DP; Bhosale VM; Gudi GS; Sangana RR; Thomas A
    Bioorg Med Chem; 2013 Nov; 21(21):6542-53. PubMed ID: 24055075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity.
    Bertamino A; Iraci N; Ostacolo C; Ambrosino P; Musella S; Di Sarno V; Ciaglia T; Pepe G; Sala M; Soldovieri MV; Mosca I; Gonzalez-Rodriguez S; Fernandez-Carvajal A; Ferrer-Montiel A; Novellino E; Taglialatela M; Campiglia P; Gomez-Monterrey I
    J Med Chem; 2018 Jul; 61(14):6140-6152. PubMed ID: 29939028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
    Sałat K; Filipek B
    J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient receptor potential channel TRPM8 agonists stimulate calcium influx and neurotensin secretion in neuroendocrine tumor cells.
    Mergler S; Strowski MZ; Kaiser S; Plath T; Giesecke Y; Neumann M; Hosokawa H; Kobayashi S; Langrehr J; Neuhaus P; Plöckinger U; Wiedenmann B; Grötzinger C
    Neuroendocrinology; 2007; 85(2):81-92. PubMed ID: 17426390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
    Beccari AR; Gemei M; Lo Monte M; Menegatti N; Fanton M; Pedretti A; Bovolenta S; Nucci C; Molteni A; Rossignoli A; Brandolini L; Taddei A; Za L; Liberati C; Vistoli G
    Sci Rep; 2017 Sep; 7(1):10999. PubMed ID: 28887460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles.
    Ognyanov VI; Balan C; Bannon AW; Bo Y; Dominguez C; Fotsch C; Gore VK; Klionsky L; Ma VV; Qian YX; Tamir R; Wang X; Xi N; Xu S; Zhu D; Gavva NR; Treanor JJ; Norman MH
    J Med Chem; 2006 Jun; 49(12):3719-42. PubMed ID: 16759115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice.
    Gauchan P; Andoh T; Kato A; Kuraishi Y
    Neurosci Lett; 2009 Jul; 458(2):93-5. PubMed ID: 19375484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats.
    Katsura H; Obata K; Mizushima T; Yamanaka H; Kobayashi K; Dai Y; Fukuoka T; Tokunaga A; Sakagami M; Noguchi K
    Exp Neurol; 2006 Jul; 200(1):112-23. PubMed ID: 16546170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia.
    Lehto SG; Weyer AD; Zhang M; Youngblood BD; Wang J; Wang W; Kerstein PC; Davis C; Wild KD; Stucky CL; Gavva NR
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Apr; 388(4):465-76. PubMed ID: 25662185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.
    Ohmi M; Shishido Y; Inoue T; Ando K; Fujiuchi A; Yamada A; Watanabe S; Kawamura K
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5364-8. PubMed ID: 25455182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
    McCauley JA; Theberge CR; Romano JJ; Billings SB; Anderson KD; Claremon DA; Freidinger RM; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Xia M; Cunningham ME; Bednar B; Stump GL; Lynch JJ; Macaulay A; Wafford KA; Koblan KS; Liverton NJ
    J Med Chem; 2004 Apr; 47(8):2089-96. PubMed ID: 15056006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.